Figures & data
Table 1. Controlled clinical trials using the KD in cancer patients published until October 2019. See Klement et al. [Citation6] for more details. HGG: High grade glioma; HNC: Head and neck cancer; N_KD: Number of patients in KD group included in the analysis; N_CTRL: Number of patients in the control group included in the analysis.
Klement RJ, Brehm N, Sweeney RA. Ketogenic diets in medical oncology: a systematic review with focus on clinical outcomes. Med Oncol. 2020;37(2):14. Rieger J, Bähr O, Maurer GD, et al. ERGO: A pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol. 2014;44(6):1843–1852. Santos JG, Da Cruz WMS, Schönthal AH, et al. Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma. Oncol Lett. 2018;15(1):1263–1270. Cohen CW, Fontaine KR, Arend RC, et al. A ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer. J Nutr. 2018;148(8):1253–1260. Furukawa K, Shigematsu K, Iwase Y, et al. Clinical effects of 1 year of chemotherapy with a modified medium-chain triglyceride ketogenic diet on the recurrence of stage IV colon cancer. J Jpn Soc Parenter Enter Nutr. 2018;33:1139–1146. . Klement RJ, Schäfer G, Sweeney RA. A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: an interim analysis of the KETOCOMP study. J Tradit Complement Med. 2019. DOI:10.1016/j.jtcme.2019.03.007 Khodabakhshi A, Akbari ME, Mirzaei HR, et al. Feasibility, safety, and beneficial effects of MCT-based ketogenic diet for breast cancer treatment: a randomized controlled trial study. Nutr Cancer. 2019:1–8.